Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine. Wiese MD, Suppiah V, O'Doherty C Expert Opin Drug Metab Toxicol. 2014 Jun 9:1-15. PMID: 24910969. Abstract CommentRecommendBookmarkWatch